✦ LIBER ✦
Anti-CD3 antibody visilizumab is not effective in patients with intravenous corticosteroid-refractory ulcerative colitis
✍ Scribed by Sandborn, W. J.; Colombel, J. F.; Frankel, M.; Hommes, D.; Lowder, J. N.; Mayer, L.; Plevy, S.; Stokkers, P.; Travis, S.; Van Assche, G.; Baumgart, D. C.; Targan, S. R.
- Book ID
- 121656122
- Publisher
- BMJ Publishing Group
- Year
- 2010
- Tongue
- English
- Weight
- 153 KB
- Volume
- 59
- Category
- Article
- ISSN
- 0017-5749
No coin nor oath required. For personal study only.